NEW YORK (Reuters) - U.S. stock index futures rose on Monday, after a two-week decline pushed the S&P 500 back into negative territory for the year, as investors anticipated the start of the corporate earnings season.
LONDON (Reuters) - Shire Plc has agreed to buy U.S. group NPS Pharmaceuticals Inc for $5.2 billion, the Dublin-based drugmaker's biggest acquisition yet as it seeks to strengthen its position in the lucrative field of medicines for rare diseases.
DETROIT (Reuters) - General Motors Co on Monday showed its Chevrolet Bolt concept car with an electric driving range of more than 200 miles and a $30,000 price tag, offering a view into where the U.S. automaker is pushing in development of electric vehicles (EV).
ZURICH/LOS ANGELES (Reuters) - Roche Holding will acquire a majority stake in molecular and genomic analysis business Foundation Medicine, it said on Monday, signaling its determination to expand in cancer immunotherapy by paying a hefty mark-up on the U.S. company's current price.
NEW YORK (Reuters) - With nearly a quarter of U.S. energy shares' value wiped out by oil's six-month slide, investors are wondering if the sector has taken enough punishment and whether it is time to pile back in ahead of earnings reports later this month.